WENDY ROCKWELL

• National, Regional, & Federal Payers, PBMs and IDN Accounts
• Innovative problem solving & collaboration for Buy & Bill/Rare Disease medication with Dialysis, Sales, and Management Markets teams
• Monitored team performance and provided constructive feedback to increase productivity and maintain quality standards.
• Assisted in recruitment of new team members, hiring highest qualified to build team of top performers.
• Communicated KPIs outlined in annual plan to inform employees of expectations and deliverables.
• Educated staff on organizational mission and goals to help employees achieve success.
• Developed effective improvement plans in alignment with goals and specifications.
• Created and managed project plans, timelines and budgets.

Accomplishments

• 2022-2023 Executed national initiative in Veteran’s Affairs Medical Centers, collaborating with Managed Markets, Sales, Medical teams, while establishing CRM infrastructure, innovative resources, training, metrics, and contracting with positive contract profitable
• Launched Korsuva for CKD-aP with 100% payer coverage and solved for Dialysis Organization reimbursement challenges
• Payer & IDN Relationships, Veltassa addition to formulary and signed GPO letter of participations in 16+ hospital systems in a year
• 2022-2023 CVS custom and template downstream pull-through for Veltassa for 2.8 million patients in regional accounts
• 2022-2023 ESI customer and template downstream pull-through for Veltassa for 2 million patients in regional accounts
• 2022-2023 Direct contract for Veltassa covering 1 million patients
• 2022-2023 Direct contract with California Medicaid covering 14 million lives
• 2022-2023 Specialized pricing for Federal Accounts 9 million lives
• 2022-, Contracting/Negotiations with Fee-for-Service Medicaids in CA, CO, AZ TX, OK, MO, IA, SSDC, TOP$
• 2023 Kaiser Permanente Vendor Contract
• 2021-2022 Recruited, hired, and trained new team of 6 Regional Managers

• Specialty Pharmacy Management: Contracting, Invoicing, Data Review, Metrics Review, Prior Authorization Review, US Coverage
• National Payers: Review Medical Policy, Contracting, Access to Medications, Create Mutually Beneficial B2B Relationships
• Managed, supported and grew business relationships with existing accounts and developed strategies to increase sales and revenue.

Accomplishments

• Forecasted sales and established processes to achieve sales objectives and related metrics.
• 2020 Grew sales with Kineret by 10000% in pivotal account through top-down efforts with no sales support
• 2020 Developed new approach and assets to address gaps of Synagis Prior-Authorizations within guidance resulting in 70 changes
• 2020 Kaiser Permanente California: Retained orphan disease status with exclusive contract despite generic intrusion
• 2019-2020 Season Solved access for ~500 patients in collaboration with Kaiser Permanente Washington
• 2019 Solved for Colorado Medicaid Home Health for ~500 patients
• 2019 Selected for Rare Disease ‘Ted Talk’ presenter at National Meeting
• 2018-2019 Launched rare disease infusion for primary HLH in 2 months while managing over 200 accounts. Solved for targets

Core accounts: Kaiser Permanente, EnvisionRx, Centene, Change Healthcare, Humana Specialty Pharmacy, Lumicera Specialty Pharmacy, MedImpact, Perform Specialty Pharmacy

• Developed strong analytical and financial skills, which helped to anticipate market and company needs.
• Lead for global pricing research in EU, Japan, Brazil, Australia, Canada, China, Russia for 5 possible indications
• Coordinate all research, communication with global market; develop launch sequence and IRP, present to senior leaders

Accomplishments

• Completed 77 pricing contracts and tenders in Europe, Canada, and Latin America for rare disease products
• Carefully monitored market trends to ascertain best pricing for company's products.
• Assessed profitability in effort to make adjustments using both company and marketplace data to develop decisive pricing.
• Analyzed plans and specifications to identify scope and cost of project.

• Developed pre-commercialization strategic insights and relationships for a diverse customer mix

Accomplishments

• Business-to-Business Leadership Exchanges with prioritized accounts including Providence Healthcare, Sharp Healthcare, and Texas Health & Human Services to explore Centers of Excellence and Research capabilities
• Increased account responsibility and interaction by 90% to cover 30 IDNs, 37+ Payers, 1 MAC, 30% of nation, ~78M lives
• Co-developed Managed Markets One-Year Learning Journey resulting in 6 new structures, including HEOR Certification
• Core accounts: Providence Healthcare & Payer, Intermountain Healthcare & Select Health, Sharp Healthcare & Payer, Texas Health & Human Services, Healthfirst Colorado, California Medi-Cal

• Managed accounts to retain existing relationships and grow share of business.
• Built relationships with Regional Payers and IDNs to establish long-term business growth.
• Liaised with sales, marketing, and management teams to develop solutions and accomplish shared objectives.

Accomplishments

• Promoted to develop strategic insights and relationships for a diverse customer mix, 30 products: 829M in annual revenue
• 2014 Tapped to establish new division, which encompassed IDNs, Employers, Payers
• Awarded merit increases between 8-12%, Long Term Incentive Retention Bonuses and ranked in top 10%
• Created novel collaborations with DaVita International (COPD), US Oncology National (Targeted Therapy), HCA National (Cardiovascular and Oncology), and Anthem/UCHealth (COPD)
• 2016 Increased Sales vs 2015 by 47% (31,686K) vs Region 31% and Nation 32% through cross-functional leadership
• 2016 Increased Symbicort Commercial Sales by 20%; leading the nation in market share and Dulera conversion with United
• 2016 Drove Gross Sales Goal Achievement from 45th in Nation in Q2 to 4th in Nation by Q4 through prioritization of key opportunities
• Successfully launched 9 products and 4 new indications: Oncology, Diabetes, Respiratory, CV, GI, Infectious, Biologic
• 2016 Pioneered and led cross-functional National Catholic Health team and thwarted negative hospital pharmacy change increasing Symbicort retail sales 12%
• 2016 Added Movantik to CHI hospital formulary increasing hospital sales by 247%; retail sales 50% nationwide
• 2016 Recipient of 1st ever Quarterly Excellence Award
• Blocked preferred competitor product at Brilinta to Colorado Medicaid resulting in 1st ever Sole & Exclusive formulary; overall market increase of 78%
• 2015 Raging Bull Award for unencumbered access of Movantik with Colorado Medicaid
• Stratified 3 core & 10 developmental accounts, developed executive level contacts from 3 to 150, and created novel data analytics to evaluate landscape and drive revenue through stakeholder engagement and team leadership
• Account focus: DaVita; Catholic Health Initiatives; UCHealth; SCL Health; Centura Health; Medicaid CO, WY & MT; Rocky Mountain Health Plan; Denver Health; HCSC MT BCBS; Anthem BCBS CO; HCA HealthOne

• Developed novel assets to include Diabetes Portfolio for Market Access and Sales
• Traveled between CA to PA every week

• Located, developed, and promoted talented employees to cultivate collaborative and hardworking sales team.
• Exceeded sales targets with well-developed sales strategy and empowering team coaching.
• Optimized team performance with newly implemented sales processes.
• Recruited, interviewed and hired employees and implemented mentoring program to promote positive feedback and engagement.
• Pinnacle Winner
• Market Access 1-year preceptorship

• Selected for highly coveted new Strategy & Operations position
• Mentorship for maximum of two years by director
• Researched and analyzed industry trends to inform sales strategies.
• Collaborated extensively with internal stakeholders to identify and implement strategies.
• Circle of Excellence
• Developed and Executed Medicare Part D and Pay for Performance Curriculum and Strategy Plan

• Skilled at working independently and collaboratively in a team environment.
• Self-motivated, with a strong sense of personal responsibility.
• Proven ability to learn quickly and adapt to new situations.
• Worked well in a team setting, providing support and guidance.

Awarded national award for HEDIS initiative